Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELAPEGADEMASE-LVLR for Immunodeficiency: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where ELAPEGADEMASE-LVLR was used for Immunodeficiency.

Most Reported Side Effects for ELAPEGADEMASE-LVLR

Side Effect Reports % Deaths Hosp.
Nasopharyngitis 29 11.3% 0 0
Covid-19 21 8.2% 0 2
Cough 20 7.8% 0 1
Bone marrow transplant 13 5.1% 0 4
Sinusitis 12 4.7% 0 1
Weight decreased 12 4.7% 0 2
Pyrexia 10 3.9% 0 4
Injection site pain 9 3.5% 0 0
Pneumonia 9 3.5% 1 7
Product dose omission 8 3.1% 0 0
Rhinorrhoea 8 3.1% 0 0
Rash 7 2.7% 0 1
Weight increased 7 2.7% 0 0
Diarrhoea 6 2.3% 0 0
Headache 6 2.3% 0 1

Other Indications for ELAPEGADEMASE-LVLR

Combined immunodeficiency (242) Product used for unknown indication (7)

Other Drugs Used for Immunodeficiency

HUMAN IMMUNOGLOBULIN G (2,648) HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (404) HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (224) CILGAVIMAB\TIXAGEVIMAB (76) DUPILUMAB (55) METRONIDAZOLE (35) MEROPENEM (28) VALACYCLOVIR (26) TOCILIZUMAB (24) ABATACEPT (23)

Related Pages

ELAPEGADEMASE-LVLR Full Profile All Immunodeficiency Drugs ELAPEGADEMASE-LVLR Demographics ELAPEGADEMASE-LVLR Timeline